Return On Equity of Landos Biopharma, Inc. from 30 Sep 2021 to 31 Mar 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Landos Biopharma, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2021 to 31 Mar 2024.
  • Landos Biopharma, Inc. Return On Equity for the quarter ending 31 Mar 2024 was -73%, a 8.9% decline year-over-year.
  • Landos Biopharma, Inc. annual Return On Equity for 2023 was -55%, a 31% increase from 2022.
  • Landos Biopharma, Inc. annual Return On Equity for 2022 was -80%, a 96% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Landos Biopharma, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2024 -73% -6% -8.9% 01 Jan 2024 31 Mar 2024
Q4 2023 -55% +25% +31% 01 Oct 2023 31 Dec 2023
Q3 2023 -50% +42% +46% 01 Jul 2023 30 Sep 2023
Q2 2023 -53% +30% +36% 01 Apr 2023 30 Jun 2023
Q1 2023 -67% -16% -30% 01 Jan 2023 31 Mar 2023
Q4 2022 -80% -39% -96% 01 Oct 2022 31 Dec 2022
Q3 2022 -93% -44% -92% 01 Jul 2022 30 Sep 2022
Q2 2022 -83% 01 Apr 2022 30 Jun 2022
Q1 2022 -51% 01 Jan 2022 31 Mar 2022
Q4 2021 -41% 01 Oct 2021 31 Dec 2021
Q3 2021 -48% 01 Jul 2021 30 Sep 2021

Landos Biopharma, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2023 -55% +25% +31% 01 Jan 2023 31 Dec 2023
2022 -80% -39% -96% 01 Jan 2022 31 Dec 2022
2021 -41% 01 Jan 2021 31 Dec 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.